Home/Filings/4/0001181431-14-011110
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001181431-14-011110

CIK 0001292519operating

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:58 PM ET

Size

8.2 KB

Accession

0001181431-14-011110

Insider Transaction Report

Form 4
Period: 2014-03-03
REYNOLDS FRANCIS
DirectorCEO, CFO10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-04$2.52/sh12,500$31,5009,761,420 total
  • Sale

    Common Stock

    2014-03-05$2.44/sh12,500$30,5009,748,920 total
  • Sale

    Common Stock

    2014-03-03$2.52/sh12,500$31,5009,773,920 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    23,488
Footnotes (3)
  • [F1]All sales between $2.41 - $2.60.
  • [F2]All sales between $2.51 - $2.56.
  • [F3]All sales between $2.32 - $2.54.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:58 PM ET
Size
8.2 KB